Encapsulation of catechin and epicatechin on BSA NPs improved their stability and antioxidant potential

EXCLI Journal

Volumn 13, Issue , 2014, Pages 331-346

  Yadav, Ramdhan ^a,b   Kumar, Dharmesh ^a   Kumari, Avnesh ^a   Yadav, Sudesh Kumar ^a,b  

^a CSIR INSTITUTE OF HIMALAYAN BIORESOURCE TECHNOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Antioxidant activity; Bovine serum albumin; Catechin; Epicatechin; Nanoparticles; Temperature stability

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; BOVINE SERUM ALBUMIN; CATECHIN; EPICATECHIN; NANOPARTICLE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG STABILITY; ELECTRON MICROSCOPE; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOENCAPSULATION; SUSTAINED DRUG RELEASE;

EID: 84899129974     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Abbasi S, Paul A, Shao W, Prakash S. Cationic al-bumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assess-ment. J Drug Del 2012;2012:1-8.
2. Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012;14: 1-16.
3. Amic D, Davidovic D, Bešlo D, Trinajstic N. Struc-ture-radical scavenging activity relationships of fla-vonoids. Croat Chem Acta 2003;76:55-61.
4. Andrew HW, Rauth M, Bendayan R, Manias JL, Ramaswamy M, Liu Z et al. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res 2006;23:1574-84.
5. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanopar-ticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 2002;79:123-35.
6. Bansal A, Kapoor DN, Kapil R, Chhabra N, Dhawan S. Design and development of paclitaxel-loaded bo-vine serum albumin nanoparticles for brain target-ing. Acta Pharm 2011;61:141-56.
7. Bark KM, Yeom JE, Yang JI, Yang IJ, Park CH, Park HR. Spectroscopic studies on the oxidation of catechin in aqueous solution. Bull Korean Chem Soc 2011;32:3443-47.
8. Bennet D, Marimuthu M, Kim S, An J. Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery. Int J Nanomed 2012;7:3399-19.
9. Bilthariya U, Jain N, Rajoriya V, Jain AK. Folate-conjugated albumin nanoparticles for rheumatoid ar-thritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm (2013) (Epub ahead of print) (doi: 10.3109/ 03639045.2013.850705).
10. Brzoska M, Langer K, Coester C, Loitsch S, Wagner TOF, Mallinckrodta CV. Incorporation of biode-gradable nanoparticles into human airway epitheli-um cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem Biophys Res Commun 2004;318:562-70.
11. Catterall F, King LJ, Clifford MN, Ioannides C. Bio-availability of dietary doses of 3H-labelled tea anti-oxidants (+)-catechin and (-)-epicatechin in rat. Xe-nobiotica 2003;33:743-53.
12. Chen F, Shi Z, Neoh KG, Kang ET. Antioxidant and antibacterial activities of eugenol and carvacrol-grafted chitosan nanoparticles. Biotechnol Bioeng 2009;104:30-39.
13. Chen YC, Yu SH, Tsai GJ, Tang DW, Mi FL, Peng YP. Novel technology for the preparation of self-assembled catechin/gelatin nanoparticles and their characterization. J Agri Food Chem 2010;58:6728-34.
14. Chitkara D, Kumar N. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs. Pharm Res 2013;30:2396-409.
15. Chu KO, Wang CC, Rogers MS, Choy KW, Pang CP. Determination of catechins and catechin gallates in biological fluids by HPLC with coulometric array detection and solid phase extraction. Anal Chim Ac-ta 2004;510:69-76.
16. Das S, Banerjee R, Bellare J. Aspirin loaded albu-min nanoparticles by coacervation: implications in drug delivery. Trend Biomater Artif Org 2005;18: 203-12.
17. Davda J, Labhasetwar V. Characterization of nano-particle uptake by endothelial cells. Int J Pharm 2002;233:51-9.
18. Derakhshandeh K, Erfan M, Dadashzadeh S. Encap-sulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial de-sign, characterization and release kinetics. Eur J Pharm Biopharm 2007;66:34-41.
19. Dube A, Ng K, Nicalazgo JA, Larson I. Effective use of reducing agents and nanoparticle encapsula-tion in stabilising catechins in alkaline solution. Food Chem 2010;122:662-7.
20. Dufort S, Sancey L, Coll JL. Physico-chemical pa-rameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv Drug Deliv Rev 2012;64:179-89.
21. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012;157: 168-82.
22. Fang R, Jing H, Chai Z, Zhao G, Stoll S, Ren F et al. Design and characterization of protein-quercetin bi-oactive nanoparticles. J Nanobiotechnol 2011;9:1-19.
23. Freitas C, Müller RH. Effect of light and tempera-ture on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm 1998;168:221-9.
24. Fresta M, Puglisi G, Giammona G, Cavallaro G, Mi-cali N, Furneri PM. Pefloxacin mesilate-and ofloxa-cin-loaded polyethylcyanoacrylate nanoparticles; characterization of the colloidal drug carrier formu-lation. J Pharm Sci 1995;84:895-901.
25. Haris PI. Can infrared spectroscopy provide infor-mation on protein-protein interactions? Biochem Soc Trans 2010;38:940-6.
26. Huang X, Teng X, Chen D, Tang F, He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 2010; 31:438-48.
27. Inniguez-Franco F, Soto-Valdez H, Peralta E, Ayala-Zavala JF, Auras R, Gámez-Meza N. Antioxidant activity and diffusion of catechin and epicatechin from antioxidant active films made of poly(L-lactic acid). J Agric Food Chem 2012;60:6515-23.
28. Jun JY, Nguyen HH, Paik SYR, Chun HS, Kang BC, Ko S. Preparation of size-controlled bovine se-rum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem 2011;127:1892-8.
29. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012;41:2971-3010.
30. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavo-noid intake and coronary mortality in Finland: a co-hort study. Br Med J 1996;312:478-81.
31. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Phar-macol 2004;500:177-85.
32. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery sys-tems. Coll Surf B Biointerfaces 2010a;75:1-18.
33. Kumari A, Yadav SK, Pakade YB, Singh B, Yadav SC. Development of biodegradable nanoparticles for delivery of quercetin. Colloid Surf B Biointerfaces 2010b;80:184-92.
34. Kumari A, Yadav SK, Pakade YB, Kumar V, Singh B, Chaudhary et al. Nanoencapsulation and charac-terization of Albizia chinensis isolated antioxidant quercitrin on PLA nanoparticles. Colloid Surf B Biointerfaces 2011;82:224-32.
35. Kumari A, Kumar V, Yadav SK. Plant extract syn-thesized PLA nanoparticles for controlled and sus-tained release of quercetin: a green approach. PLoS one 2012;7:e41230.
36. Kvi{dotless}tek L, Panacek A, Soukupova J, Kolar M, Vece-rova R, Prucek R et al. Effect of surfactants and pol-ymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C 2008;112:5825-34.
37. Li DL, Li XM, Peng ZY, Wang BG. Flavanol deri-vatives from Rhizophora stylosa and their DPPH radical scavenging activity. Molecules 2007;12: 1163-9.
38. Li D, Martini N, Wu Z, Wen J. Development of an isocratic HPLC method for catechin quantification and its application to formulation studies. Fitoterapia 2012;83:1267-74.
39. Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB et al. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int J Pharm 2008;349:274-82.
40. Ma R, Levard C, Marinakos SM, Cheng Y, Liu J, Michel FM et al. Size-controlled dissolution of or-ganic-coated silver nanoparticles. Environ Sci Tech-nol 2012;46:752-9.
41. Madlova M, Jones SA, Zwerschke I, Ma Y, Hider RC, Forbes B. Poly (vinyl alcohol) nanoparticle sta-bility in biological media and uptake in respiratory epithelial cell layers in vitro. Eur J Pharm Biopharm 2009;72:437-43.
42. Maghsoudi A, Shojaosadati SA, Farahani EV. 5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study. AAPS Pharm Sci Tech 2008;9:1092-6.
43. Maoela MS, Arotiba OA, Baker PGL, Mabusela WT, Jahed N, Songa EA et al. Electroanalytical de-termination of catechin flavonoid in ethyl acetate ex-tracts of medicinal plants. Int J Electrochem Sci 2009;4:1497-510.
44. Maurya PK, Rizvi SI. Protective role of tea cate-chins on erythrocytes subjected to oxidative stress during human aging. Nat Prod Res 2009;23:1072-9.
45. McGugan EA. Hyperpyrexia in the emergency de-partment. Emerg Med (Fremantle) 2001;13:116-20.
46. Moghimi SM, Hunter AC, Murray JC. Long-circula-ting and target-specific nanoparticles: theory to prac-tice. Pharmacol Rev 2001;53:283-318.
47. Molyneux P. The use of the stable free radical di-phenylpicrylhydrazyl (DPPH) for estimating antiox-idant activity. Songklanakarin J Sci Technol 2004; 26:211-9.
48. Muller BG, Leuenberger H, Kissel T. Albumin na-nospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm Res 1996;13:1332-7.
49. Munin A, Edwards-Levy F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics 2011;3:793-829.
50. Muthu MS, Feng SS. Pharmaceutical stability as-pects of nanomedicines. Nanomedicine 2009;4:857-60.
51. Nagarajan S, Nagarajan R, Braunhut SJ, Bruno F, McIntosh D, Samuelson L et al. Biocatalytically oli-gomerized epicatechin with potent and specific anti-proliferative activity for human breast cancer cells. Molecules 2008;13:2704-16.
52. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P et al. Understanding biophysico-chemical interactions at the nano-bio interface. Nat Mater 2009;8:543-57.
53. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Reparations of biodegradable nanospheres of wa-ter-soluble and insoluble drugs with D, L-lactide/ glycolide copolymer by a novel spontaneous emulsi-fication solvent diffusion method and the drug re-lease behavior. J Control Release 1993;25:89-98.
54. Park JH, Ye M, Park K. Biodegradable polymers for microencapsulation of drugs. Molecules 2005;10: 146-61.
55. Patil GV. Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res 2003;58:219-47.
56. Pool H, Quintanar D, Figueroa JD, Mano CM, Be-chara JEH, Godi{dotless}nez LA et al. Antioxidant effects of quercetin and catechin encapsulated into PLGA na-noparticles. J Nanomater 2012;2012:1-12 (article No. 86).
57. Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoen-capsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nano-technol Biol Med 2006;2:8-21.
58. Sadhukha T, Wiedmann TS, Panyam J. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 2013;34:5163-71.
59. Sailja AK, Amareshwar P. Prepration of BSA nano-particles by desolvation technique using acetone as desolvating agent. Int J Pharm Sci Nanotech 2012; 5:1643-7.
60. Sebak S, Mirzaei M, Malhotra M, Kulamarva A, Prakash S. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for po-tential use in breast cancer: preparation and in vitro analysis. Int J Nanomed 2010;5:525-32.
61. Shafique K, McLoone P, Qureshic K, Leungd H, Hart C, Morrison DS. Tea consumption and the risk of overall and grade specific prostate cancer: a large prospective cohort study of Scottish men. Nutr Can-cer 2012;64:790-7.
62. Shang L, Wang Y, Jiang J, Dong S. pH-dependent protein conformational changes in albumin:dold na-noparticle bioconjugates: A spectroscopic study. Langmuir 2007;23:2714-21.
63. Singh AV, Bandgar BM, Kasture M, Prasad BLV, Sastry M. Synthesis of gold, silver and their alloy nanoparticles using bovine serum albumin as foam-ing and stabilizing agent. J Mater Chem 2005;15: 5115-21.
64. Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and ac-tions. Mut Res 2005;579:200-13.
65. Volf I, Ignat I, Neamtu M, Popa VI. Thermal stabil-ity, antioxidant activity, and photo-oxidation of nat-ural polyphenols. Chem Pap 2014;68:121-9.
66. Von Burkersroda F, Schedl L, Göpferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 2002;23:4221-31.
67. Xie L, Tong W, Yu D, Xu J, Li J, Gao C. Bovine se-rum albumin nanoparticles modified with multi-layers and aptamers for pH-responsive and targeted anti-cancer drug delivery. J Mater Chem 2012;22: 6053-60.
68. Yadav SC, Kumari A, Yadav R. Development of peptide and protein nanotherapeutics by nanoencap-sulation and nanobioconjugation. Peptides 2011;32: 173-87.
69. Yadav R, Kumar D, Kumari A, Yadav SK. Encapsu-lation of podophyllotoxin and etoposide in biode-gradable poly-D, L-lactide nanoparticles improved their anticancer activity. J Microencapsul (2013) (Epub ahead of print) (doi: 10.3109/02652048.2013. 834988).
70. Yogasundaram H, Bahniuk MS, Singh HD, Aliabadi HM, Uludaǧ H, Unsworth LD. BSA nanoparticles for siRNA delivery: coating effects on nanoparticle properties, plasma protein adsorption, and in vitro siRNA delivery. Int J Biomater 2012;2012:1-10.
71. Yoo HS, Oh JE, Lee KH, Park TG. Biodegradable nanoparticles containing doxorubicin-PLGA conju-gate for sustained release. Pharm Res 1999;16:1114-8.
72. Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. Preparation and characterization of pro-tein C-loaded PLA nanoparticles. J Control Release 1999;60:179-88.
73. Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed 2010; 5:669-77.
74. Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH. Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2013;97:750-62.